vs
LifeStance Health Group, Inc.（LFST）与Orion S.A.（OEC）财务数据对比。点击上方公司名可切换其他公司
Orion S.A.的季度营收约是LifeStance Health Group, Inc.的1.1倍（$411.7M vs $382.2M），LifeStance Health Group, Inc.同比增速更快（17.4% vs -5.2%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $44.2M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs -9.5%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
奥里昂集团成立于1917年，总部位于芬兰埃斯波，是一家全球化运营的芬兰企业。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分，旗下所有生产基地及大部分研发部门均设于芬兰境内。
LFST vs OEC — 直观对比
营收规模更大
OEC
是对方的1.1倍
$382.2M
营收增速更快
LFST
高出22.6%
-5.2%
自由现金流更多
LFST
多$2.4M
$44.2M
两年增速更快
LFST
近两年复合增速
-9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $411.7M |
| 净利润 | $11.7M | — |
| 毛利率 | — | 18.9% |
| 营业利润率 | 4.7% | 4.3% |
| 净利率 | 3.1% | — |
| 营收同比 | 17.4% | -5.2% |
| 净利润同比 | 264.1% | — |
| 每股收益（稀释后） | — | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTOEC
| Q4 25 | $382.2M | $411.7M | ||
| Q3 25 | $363.8M | $450.9M | ||
| Q2 25 | $345.3M | $466.4M | ||
| Q1 25 | $333.0M | $477.7M | ||
| Q4 24 | $325.5M | $434.2M | ||
| Q3 24 | $312.7M | $463.4M | ||
| Q2 24 | $312.3M | $477.0M | ||
| Q1 24 | $300.4M | $502.9M |
净利润LFSTOEC
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.1M | $-67.1M | ||
| Q2 25 | $-3.8M | $9.0M | ||
| Q1 25 | $709.0K | $9.1M | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-6.0M | $-20.2M | ||
| Q2 24 | $-23.3M | $20.5M | ||
| Q1 24 | $-21.1M | $26.7M |
毛利率LFSTOEC
| Q4 25 | — | 18.9% | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 20.5% | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 23.0% | ||
| Q1 24 | — | 24.3% |
营业利润率LFSTOEC
| Q4 25 | 4.7% | 4.3% | ||
| Q3 25 | 2.0% | -11.9% | ||
| Q2 25 | -0.9% | 6.9% | ||
| Q1 25 | 0.5% | 6.5% | ||
| Q4 24 | 0.3% | 5.4% | ||
| Q3 24 | 0.0% | -3.3% | ||
| Q2 24 | -5.1% | 8.7% | ||
| Q1 24 | -5.6% | 10.5% |
净利率LFSTOEC
| Q4 25 | 3.1% | — | ||
| Q3 25 | 0.3% | -14.9% | ||
| Q2 25 | -1.1% | 1.9% | ||
| Q1 25 | 0.2% | 1.9% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -1.9% | -4.4% | ||
| Q2 24 | -7.5% | 4.3% | ||
| Q1 24 | -7.0% | 5.3% |
每股收益（稀释后）LFSTOEC
| Q4 25 | — | $-0.36 | ||
| Q3 25 | — | $-1.20 | ||
| Q2 25 | — | $0.16 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.31 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $0.35 | ||
| Q1 24 | — | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $60.7M |
| 总债务越低越好 | $282.8M | — |
| 股东权益账面价值 | $1.5B | $384.6M |
| 总资产 | $2.2B | $1.9B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTOEC
| Q4 25 | $248.6M | $60.7M | ||
| Q3 25 | $203.9M | $51.3M | ||
| Q2 25 | $188.9M | $42.6M | ||
| Q1 25 | $134.3M | $37.5M | ||
| Q4 24 | $154.6M | $44.2M | ||
| Q3 24 | $102.6M | $53.2M | ||
| Q2 24 | $87.0M | $34.2M | ||
| Q1 24 | $49.5M | $43.9M |
总债务LFSTOEC
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
股东权益LFSTOEC
| Q4 25 | $1.5B | $384.6M | ||
| Q3 25 | $1.5B | $401.8M | ||
| Q2 25 | $1.5B | $466.5M | ||
| Q1 25 | $1.5B | $466.1M | ||
| Q4 24 | $1.4B | $474.9M | ||
| Q3 24 | $1.4B | $476.3M | ||
| Q2 24 | $1.4B | $503.9M | ||
| Q1 24 | $1.4B | $492.2M |
总资产LFSTOEC
| Q4 25 | $2.2B | $1.9B | ||
| Q3 25 | $2.1B | $2.0B | ||
| Q2 25 | $2.1B | $2.0B | ||
| Q1 25 | $2.1B | $2.0B | ||
| Q4 24 | $2.1B | $1.9B | ||
| Q3 24 | $2.1B | $2.0B | ||
| Q2 24 | $2.1B | $1.9B | ||
| Q1 24 | $2.1B | $1.9B |
负债/权益比LFSTOEC
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $92.9M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $44.2M |
| 自由现金流率自由现金流/营收 | 12.2% | 10.7% |
| 资本支出强度资本支出/营收 | 2.9% | 11.8% |
| 现金转化率经营现金流/净利润 | 4.93× | — |
| 过去12个月自由现金流最近4个季度 | $110.0M | $54.8M |
8季度趋势，按日历期对齐
经营现金流LFSTOEC
| Q4 25 | $57.6M | $92.9M | ||
| Q3 25 | $27.3M | $68.8M | ||
| Q2 25 | $64.4M | $53.7M | ||
| Q1 25 | $-3.1M | $400.0K | ||
| Q4 24 | $62.3M | $94.5M | ||
| Q3 24 | $22.7M | $-30.9M | ||
| Q2 24 | $44.1M | $29.3M | ||
| Q1 24 | $-21.8M | $32.4M |
自由现金流LFSTOEC
| Q4 25 | $46.6M | $44.2M | ||
| Q3 25 | $17.0M | $27.9M | ||
| Q2 25 | $56.6M | $11.5M | ||
| Q1 25 | $-10.3M | $-28.8M | ||
| Q4 24 | $56.0M | $23.5M | ||
| Q3 24 | $17.7M | $-78.8M | ||
| Q2 24 | $39.0M | $-25.4M | ||
| Q1 24 | $-26.9M | $-700.0K |
自由现金流率LFSTOEC
| Q4 25 | 12.2% | 10.7% | ||
| Q3 25 | 4.7% | 6.2% | ||
| Q2 25 | 16.4% | 2.5% | ||
| Q1 25 | -3.1% | -6.0% | ||
| Q4 24 | 17.2% | 5.4% | ||
| Q3 24 | 5.7% | -17.0% | ||
| Q2 24 | 12.5% | -5.3% | ||
| Q1 24 | -9.0% | -0.1% |
资本支出强度LFSTOEC
| Q4 25 | 2.9% | 11.8% | ||
| Q3 25 | 2.8% | 9.1% | ||
| Q2 25 | 2.2% | 9.0% | ||
| Q1 25 | 2.2% | 6.1% | ||
| Q4 24 | 1.9% | 16.4% | ||
| Q3 24 | 1.6% | 10.3% | ||
| Q2 24 | 1.6% | 11.5% | ||
| Q1 24 | 1.7% | 6.6% |
现金转化率LFSTOEC
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | — | ||
| Q2 25 | — | 5.97× | ||
| Q1 25 | -4.36× | 0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.43× | ||
| Q1 24 | — | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
OEC
| Rubber | $272.0M | 66% |
| Specialties | $139.7M | 34% |
